Jul 01, 2026 Posted on 1 July 20261 July 2026 Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
Nov 14, 2024 Posted on 14 November 202414 November 2024 AstraZeneca and Merck’s Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings
